Tanke Biosciences Corp (TNBI) stock: key figures, P/E, revenue and dividend
Consumer Staples · China · ISIN US87583Y1073
Tanke Biosciences Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | – | 8,430.00 USD |
| Gross profit | -977.00 USD | 6,866.00 USD |
| Operating income | -117,421.00 USD | -257,865.00 USD |
| Net income | -119,931.00 USD | -274,464.00 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tanke Biosciences Corp
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business. The company monitors and analyses accurate, itemized, and real-time energy data. Its assets are utilized in the monitoring of energy consumption using internet of things (IoT), big data, and artificial intelligence for commercial buildings, such as food retail, quick service, multi-site commercial, education, manufacturing, and hotels. Tanke Biosciences Corporation was incorporated in 1989 and is based in Las Vegas, Nevada.
More stocks
- FOXO TECHNOLOGIES INC. (FOXO)
- AMAZE HOLDINGS, INC. (AMZE)
- Maison Solutions Inc. (MSS)
- 1606 CORP. (CBDW)
- Awareness Group, Inc. (TAAG)
- Nextel Medical Corp. (MAJI)
- Cardiff Lexington Corp (CDIX)
- MOBIX LABS, INC (MOBX)
- Longevity Health Holdings, Inc. (XAGE)
- ADVANCED OXYGEN TECHNOLOGIES INC (AOXY)
- ENCISION INC (ECIA)
- ENvue Medical, Inc. (FEED)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.